Square Pharma’s earnings jump 27%

The country’s top drug maker Square Pharmaceuticals Limited has reported a 27 per cent rise in its earnings in July-September period this fiscal compared to the previous year’s same quarter.

Its earnings per share (EPS) stood at Tk 5.64 in Q1, which was Tk 4.44 in the same period of the last year.

Its net asset value (NAV) per share stood at Tk 108.71 during the period.

The pharmaceutical giant has declared 60 per cent cash dividends for the fiscal 2020-21, which was a record in the dividend payout history of the company.

The company’s latest dividend payout broke the record it made in FY 20 when it was 47 per cent.

The company’s annual general meeting (AGM) is scheduled for December 15 to approve the dividend. The record date for the entitlement of the dividend is November 22.

According to the company sources, it reported earnings per share for the last financial year was Tk 17.99, an increase of 20 per cent in the same period a year earlier. And the consolidated EPS stood at Tk 15.07 during the period.

And on June 30, 2021, the company’s net asset value per share (NAV) stood at Tk 102.54. On Sunday, the company’s share rose to Tk 216.30 on the Dhaka Stock Exchange.

Of the total pharmaceutical market share, Square Pharmaceuticals holds 17.73 per cent, Incepta 10.21 per cent, Beximco 8.39 per cent, Opsonin 5.54 per cent, Renata 4.97 per cent, Healthcare Pharma 4.57 per cent, ACI 4.43 per cent, Aristo pharma 4.38 per cent, Eskayef 4.36 per ent, and Acme 3.91 per cent.